These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. General population screening for cystic fibrosis is premature. Biesecker L; Bowles-Biesecker B; Collins F; Kaback M; Wilfond B Am J Hum Genet; 1992 Feb; 50(2):438-9. PubMed ID: 1734723 [No Abstract] [Full Text] [Related]
26. Screening for carriers of cystic fibrosis. Raeburn S BMJ; 1994 Jun; 308(6942):1451-2. PubMed ID: 8019273 [No Abstract] [Full Text] [Related]
27. Expanded carrier screening: what the reproductive endocrinologist needs to know. Dungan J Fertil Steril; 2018 Feb; 109(2):183-189. PubMed ID: 29447660 [TBL] [Abstract][Full Text] [Related]
28. The ethics of cystic fibrosis carrier screening: where do we stand? De Braekeleer M; Mélançon MJ Am J Hum Genet; 1990 Sep; 47(3):580-1. PubMed ID: 2393029 [No Abstract] [Full Text] [Related]
29. To test or not to test? Roberts L Science; 1990 Jan; 247(4938):17-9. PubMed ID: 2294585 [No Abstract] [Full Text] [Related]
30. Whole-population screening for carriers of cystic fibrosis gene. Carswell F Lancet; 1996 May; 347(9013):1421-2. PubMed ID: 8676620 [No Abstract] [Full Text] [Related]
31. Ethnicity-Based Carrier Screening. King JR; Klugman S Obstet Gynecol Clin North Am; 2018 Mar; 45(1):83-101. PubMed ID: 29428288 [TBL] [Abstract][Full Text] [Related]
32. The impact of population based screening for carriers of cystic fibrosis. Bekker H; Denniss G; Modell M; Bobrow M; Marteau T J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812 [TBL] [Abstract][Full Text] [Related]
33. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience. Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730 [TBL] [Abstract][Full Text] [Related]
34. Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners. Delatycki MB; Laing NG; Moore SJ; Emery J; Archibald AD; Massie J; Kirk EP Aust J Gen Pract; 2019 Mar; 48(3):106-110. PubMed ID: 31256466 [TBL] [Abstract][Full Text] [Related]
35. Population screening for cystic fibrosis. Brock DJ; Manson JC Lancet; 1980 Nov; 2(8201):973-4. PubMed ID: 6159513 [No Abstract] [Full Text] [Related]
37. Direct marketing of cystic fibrosis carrier screening: commercial push or population need? Harper PS J Med Genet; 1995 Apr; 32(4):249-50. PubMed ID: 7643350 [No Abstract] [Full Text] [Related]
38. Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. Kauffman TL; Wilfond BS; Jarvik GP; Leo MC; Lynch FL; Reiss JA; Richards CS; McMullen C; Nickerson D; Dorschner MO; Goddard KA Contemp Clin Trials; 2017 Feb; 53():100-105. PubMed ID: 27940182 [TBL] [Abstract][Full Text] [Related]
39. PCR-based cystic fibrosis (CF) carrier screening in a first-year medical student biochemistry laboratory. Grody WW; Kronquist KE; Lee EU; Edmond J; Rome LH Am J Hum Genet; 1993 Dec; 53(6):1352-5. PubMed ID: 8250051 [No Abstract] [Full Text] [Related]
40. Screening and the new genetics. Cooper JD; Franks AJ J Public Health Med; 1997 Mar; 19(1):121. PubMed ID: 9138228 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]